The Systemic Synuclein Sampling Study (S4) is uniquely designed to identify a reproducible diagnostic and progression biomarker for Parkinson’s disease.
Browsing: predictive biomarker
Researchers have used MRI scans to predict risk of developing autism in infants long before symptoms occur – autism was correctly predicted in 80% of infants.
Population-based cohort study reports that increased serum NT-proBNP levels are associated with smaller brain volumes and could be used as a biomarker for disease such as stroke and dementia.
Researchers have identified a new biomarker for Parkinson’s disease in patient urine samples – the biomarker could be used in the future to monitor disease progression and treatment success.
A new study has indicated that high levels of TREM2 within monocytes are linked to an increased risk of Alzheimer’s disease. The study results help to further unravel the role of the immune system within the disease.
Genetic variants identified within a cohort of subjects with Alzheimer’s disease have been associated with a delay in age of onset of up to 10 years.
Methylation of the oxytocin receptor gene linked to postpartum depression in prenatally nondepressive women
Oxytocin receptor marker in blood could assist in identifying women at risk of postpartum depression.